Table 5.

Univariate Analysis of Clinical, Treatment and Neck Factors Association with GT Status

Clinical, Treatment, Neck Dissection Characteristics	GT1 Dependence at 12 Months		GT Dependence at 24 Months
	p-value	OR2 (95% CI)	p-value	OR (95% CI)
Primary Tumor Site (Oropharyx vs. Other)	0.52	0.7 (0.2 – 2.2)	0.57	1.9 (0.2 – 16.2)
T Stage (T1–T4)	0.003	2.3 (1.3 – 3.9)	0.03	2.2 (1.1 – 4.5)
N Stage (N1, N2a, N2b, N2c, N3)	0.08	1.5 (1.0 – 2.5)	0.69	1.1 (0.6 – 2.2)
Chemotherapy Technique (Induction vs. CRT3)	0.35	1,7 (0.6 – 5.2)	0.86	0.9 (0.2 – 3.8)
Type of ND4 (RND5 vs. MRND6)	0.77	0.8 (0.3 – 2.7)	0.3	0.3 (0.04 – 2.7)
Complications after ND:
At Least One Complication	0.60	1.3 (0.5 – 3.6)	0.4	1.8 (0.5 – 7.4)
At Least One Wound Complication	0.27	2.3 (0.5 – 10.4)	0.27	2.3 (0.5 – 10.4)
Time of ND (ND before or after 12 weeks after CRT)	0.20	1.9 (0.7 – 5.2)	0.04	4.6 (1.1 – 19.9)
Weight Loss from Start of CRT (≥10% vs. <10%)	0.34	0.6 (0.2 – 1.8)	0.48	0.6 (0.1 – 2.5)
Tracheotomy	0.11		0.06	(1.1, 25.2)

Abbreviations:

¹GT= gastrostomy tube,

²OR= odds ratio,

³CRT= chemoradiotherapy,

⁴ND= neck dissection,

⁵RND=radical neck dissection,

⁶MRND= modified radical neck dissection